Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.
Rugbjerg K, Friis S, Lassen CF, Ritz B, Olsen JH.
Int J Cancer. 2012 Jan 25. doi: 10.1002/ijc.27443. [Epub ahead of print]
Related citations
Lower sensitivity of screening mammography after previous benign breast surgery.
van Breest Smallenburg V, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, van Beek M, Louwman MW.
Int J Cancer. 2012 Jan 1;130(1):122-8. doi: 10.1002/ijc.25984. Epub 2011 May 9.
High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.
Jacquemier J, Bertucci F, Finetti P, Esterni B, Charafe-Jauffret E, Thibult ML, Houvenaeghel G, Van den Eynde B, Birnbaum D, Olive D, Xerri L.
Int J Cancer. 2012 Jan 1;130(1):96-104. doi: 10.1002/ijc.25979.
The cancer burden in the United Kingdom in 2007 due to radiotherapy.
Maddams J, Parkin DM, Darby SC.
Int J Cancer. 2011 Dec 15;129(12):2885-93. doi: 10.1002/ijc.26240. Epub 2011 Aug 9.
Kaposi sarcoma and Merkel cell carcinoma after autoimmune disease.
Hemminki K, Liu X, Ji J, Sundquist J, Sundquist K.
Int J Cancer. 2012 Aug 1;131(3):E326-8. doi: 10.1002/ijc.27376. Epub 2012 Jan 27. No abstract available.
MC1R genotypes and risk of melanoma before age 40 years: A population-based case-control-family study.
Cust AE, Goumas C, Holland EA, Agha-Hamilton C, Aitken JF, Armstrong BK, Giles GG, Kefford RF, Schmid H, Hopper JL, Mann GJ, Jenkins MA.
Int J Cancer. 2012 Aug 1;131(3):E269-81. doi: 10.1002/ijc.27357. Epub 2012 Jan 30.
Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ.
Sänger N, Effenberger KE, Riethdorf S, Van Haasteren V, Gauwerky J, Wiegratz I, Strebhardt K, Kaufmann M, Pantel K.
Int J Cancer. 2011 Nov 15;129(10):2522-6. doi: 10.1002/ijc.25895. Epub 2011 Mar 25.
Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene.
Lambert SR, Harwood CA, Purdie KJ, Gulati A, Matin RN, Romanowska M, Cerio R, Kelsell DP, Leigh IM, Proby CM.
Int J Cancer. 2012 Aug 1;131(3):E216-26. doi: 10.1002/ijc.27333. Epub 2011 Dec 21.
The metastatic microenvironment: Brain-residing melanoma metastasis and dormant micrometastasis.
Izraely S, Sagi-Assif O, Klein A, Meshel T, Tsarfaty G, Pasmanik-Chor M, Nahmias C, Couraud PO, Ateh E, Bryant JL, Hoon DS, Witz IP.
Int J Cancer. 2011 Oct 25. doi: 10.1002/ijc.27324. [Epub ahead of print]
Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696).
Schaefer C, Butterfield LH, Lee S, Kim GG, Visus C, Albers A, Kirkwood JM, Whiteside TL.
Int J Cancer. 2011 Oct 24. doi: 10.1002/ijc.26481. [Epub ahead of print]
Association of activated c-Met with NRAS-mutated human melanomas.
Chattopadhyay C, Ellerhorst JA, Ekmekcioglu S, Greene VR, Davies MA, Grimm EA.
Int J Cancer. 2012 Jul 15;131(2):E56-65. doi: 10.1002/ijc.26487. Epub 2012 Jan 11.
PRKX, TTBK2 and RSK4 expression causes sunitinib resistance in kidney carcinoma- and melanoma-cell lines.
Bender C, Ullrich A.
Int J Cancer. 2012 Jul 15;131(2):E45-55. doi: 10.1002/ijc.26486. Epub 2012 Feb 28.
Basal cell carcinoma and anthropometric factors in the U.S. radiologic technologists cohort study.
Gerstenblith MR, Rajaraman P, Khaykin E, Doody MM, Alexander BH, Linet MS, Freedman DM.
Int J Cancer. 2012 Jul 15;131(2):E149-55. doi: 10.1002/ijc.26480. Epub 2012 Jan 31.
Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes.
Carretero R, Wang E, Rodriguez AI, Reinboth J, Ascierto ML, Engle AM, Liu H, Camacho FM, Marincola FM, Garrido F, Cabrera T.
Int J Cancer. 2012 Jul 15;131(2):387-95. doi: 10.1002/ijc.26471. Epub 2011 Nov 9.
Glycosaminoglycan mimicry by COAM reduces melanoma growth through chemokine induction and function.
Piccard H, Berghmans N, Korpos E, Dillen C, Aelst IV, Li S, Martens E, Liekens S, Noppen S, Damme JV, Sorokin L, Opdenakker G.
Int J Cancer. 2011 Sep 27. doi: 10.1002/ijc.26465. [Epub ahead of print]
The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: Its impact on the chemokine expression profile, including suppression of CXCL10.
Tanese K, Grimm EA, Ekmekcioglu S.
Int J Cancer. 2011 Sep 22. doi: 10.1002/ijc.26451. [Epub ahead of print]
Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk.
Seibold P, Hein R, Schmezer P, Hall P, Liu J, Dahmen N, Flesch-Janys D, Popanda O, Chang-Claude J.
Int J Cancer. 2011 Sep 15;129(6):1467-76. doi: 10.1002/ijc.25761. Epub 2011 Jan 6.
Differential effects of the glycolysis inhibitor 2-deoxy-D-glucose on the activity of pro-apoptotic agents in metastatic melanoma cells, and induction of a cytoprotective autophagic response.
Giammarioli AM, Gambardella L, Barbati C, Pietraforte D, Tinari A, Alberton M, Gnessi L, Griffin RJ, Minetti M, Malorni W.
Int J Cancer. 2011 Sep 12. doi: 10.1002/ijc.26420. [Epub ahead of print]
A prospective, population-based study of 40,000 women regarding host factors, UV exposure and sunbed use in relation to risk and anatomic site of cutaneous melanoma.
Nielsen K, Måsbäck A, Olsson H, Ingvar C.
Int J Cancer. 2012 Aug 1;131(3):706-15. doi: 10.1002/ijc.26408. Epub 2011 Oct 20.
MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.
Schultz-Thater E, Piscuoglio S, Iezzi G, Le Magnen C, Zajac P, Carafa V, Terracciano L, Tornillo L, Spagnoli GC.
Int J Cancer. 2011 Sep 1;129(5):1137-48. doi: 10.1002/ijc.25777. Epub 2011 Jan 12.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on